"I'll teach you a lesson." Concluded successfully.
Release time:
2021-07-01
News from our newspaper 6# February 24 , as one of the highlights of the company's 2021 safety production month series of activities, the second phase of the "I'll give you a lesson" safety training was held at the group headquarters. The management personnel, production backbones and personnel from all departments and offices of the group gathered at the scene, and foreign enterprises took safety "big lessons" through video ", more effective than teaching. At this point, the "I'll give you a lesson" safety training has come to a successful conclusion.
"Big Class", Daye Peak Wu Xinqiong, Yunnan Peak Liu Fengbin, Anhui New Peak North Carolina Wang Lijun, Cable Company Wang Debo, Peak Health Zhou Guangliang, Pharmaceutical Manufacturing Department Lu Xianhui, and Group Audit Performance Department Li Xiaoyin took turns to "take the stage" to give lectures. They share their work experience in safety production from the aspects of safety risk control practice, supervision and management requirements for special operations, quality requirements of safety officers, safety culture and concept, new version of "safety production law", hidden danger investigation, how to learn lessons from accidents, etc., to spread safety knowledge and concept, and explain safety laws and regulations and systems. During the 4 hours of teaching, because the content is close to reality, the analysis is reasonable, the point of view is novel, and the explanation is vivid, the staff listened very carefully, which played a good educational effect.
Group heads of departments and offices and representatives of subordinate enterprise managers formed a "jury" with a total of 22 people to rate the teaching results of 6 teachers respectively. In the end, Li Xiaoyin won the first prize, Wu Xinqiong and Lu Xianhui won the second prize, and Wang Debo, Wang Lijun, Zhou Guangliang and Liu Fengbin won the third prize.
"Let me teach you a lesson" is a safety training activity launched by the company during this year's Safety Month. Previously, in the first stage of each production enterprise, teachers were selected within each unit, and the teachers carefully prepared the course content and combed and shared the safety work experience. The staff checked the deficiencies according to the safety requirements and tested their own safety management quality. The training form and content were positively responded by the subordinate production enterprises, and the staff participation was very high.
After the "Big Class" appraisal on 24 , Chen Tianci, chairman of the board of supervisors and member of the safety committee of the group company, fully affirmed the on-site performance of all teachers when summarizing on the spot. He believes that "I will teach you a lesson" has achieved two goals. It not only strengthens the exchange of safety management experience between enterprises, and provides new safety management ideas for brother enterprises through experience sharing, knowledge transfer and management thinking, but also because In order to teach this lesson well, teachers have consulted a lot of materials, analyzed and summarized the shortcomings of internal safety management of enterprises, and conducted in-depth thinking, promote the improvement of the quality of safety management personnel.
In view of the in-depth development of production safety work in the second half of the year, Chen Tianci put forward two hopes: I hope that the form of "I'll give you a lesson" can be maintained for a long time in the enterprise, and the teachers should improve their flexibility in the future teaching process and explain in combination with accident cases to enhance the training effect and avoid boredom. It is hoped that all enterprises will conscientiously sum up the lessons of various accidents in the first half year, in the future work, we should do a good job in safety management, especially the safety risk management and control work. Through joint management and joint efforts, we will strive to achieve the goal of zero accidents in the second half of the year.
In this activity, the participants also watched traffic safety accidents and hazardous chemicals production safety warning education films.
(Ni ZhenyuChen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page